Almost 20% of COVID-19 patients have a history of atrial fibrillation (AF), but also a new-
onset AF represents a frequent complication in COVID-19. Clinical evidence demonstrates …

Abstract Coronavirus disease 2019 (COVID-19) is a novel, highly transmittable and severe
strain disease, which has rapidly spread worldwide. Despite epidemiological evidence …

Background COVID-19 infections are known to cause numerous systemic complications
including cardiovascular disorders. In this regard, clinicians recently noticed that patients …

The health crisis due to coronavirus disease 2019 (COVID-19) has shocked the world, with
more than 1 million infections and casualties. COVID-19 can present from mild illness to …

Atrial fibrillation is a common clinical manifestation in hospitalized patients with coronavirus
disease 2019 (COVID‐19). Medications used to treat atrial fibrillation, such as antiarrhythmic …

Abstract Coronavirus disease 2019 (COVID-19) outbreak is a public health emergency of
international concerns because of a highly pathogenic human coronavirus (HCoV), actually …

Myocardial involvement during COVID-19 is frequent, and subjects with cardiac disease are
at a higher risk of myocardial injury and worse outcome. 1, 2 As correctly pointed out by …

Background There is limited data concerning the prevalence of arrhythmias, particularly
atrial fibrillation (AF), which may develop as a consequence of direct myocardial injury and …

Purpose of Review A significant proportion of patients infected by the severe acute
respiratory syndrome-coronavirus (SARS-CoV2)(COVID-19) also have disorders affecting …

The coronavirus pandemic disease 2019 (COVID-19) has changed the face of contemporary
medicine. However, each and every medical practitioner must be aware of potential early …